Although SOX-10 has been proven to be a superior marker for melanoma in skin, benign melanocytic lesions also express SOX-10; therefore, SOX-10 cannot be used to differentiate benign from malignant melanocytic skin lesions [16]. The gene discussed is SOX10; the disease is melanoma.